Cargando…
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
Co-infections with different variants of SARS-CoV-2 are a key precursor to recombination events that are likely to drive SARS-CoV-2 evolution. Rapid identification of such co-infections is required to determine their frequency in the community, particularly in populations at-risk of severe COVID-19,...
Autores principales: | Rockett, Rebecca J., Draper, Jenny, Gall, Mailie, Sim, Eby M., Arnott, Alicia, Agius, Jessica E., Johnson-Mackinnon, Jessica, Fong, Winkie, Martinez, Elena, Drew, Alexander P., Lee, Clement, Ngo, Christine, Ramsperger, Marc, Ginn, Andrew N., Wang, Qinning, Fennell, Michael, Ko, Danny, Hueston, Linda, Kairaitis, Lukas, Holmes, Edward C., O’Sullivan, Matthew N., Chen, Sharon C.-A., Kok, Jen, Dwyer, Dominic E., Sintchenko, Vitali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117272/ https://www.ncbi.nlm.nih.gov/pubmed/35585202 http://dx.doi.org/10.1038/s41467-022-30518-x |
Ejemplares similares
-
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
por: Rockett, Rebecca, et al.
Publicado: (2022) -
SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes
por: Fong, Winkie, et al.
Publicado: (2023) -
SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture
por: Agius, Jessica E., et al.
Publicado: (2022) -
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
por: Basile, Kerri, et al.
Publicado: (2022) -
Guiding the design of SARS-CoV-2 genomic surveillance by estimating the resolution of outbreak detection
por: Suster, Carl J. E., et al.
Publicado: (2022)